06

Professor Andrea Alimonti, Group Leader at the Institute of Oncology Research (IOR) and Full Professor at the Institute of Translational Medicine (D-HEST) at ETH Zurich, has been selected as the recipient of the 2024 Cloëtta Prize. This prestigious accolade represents a significant recognition of Professor Alimonti's exceptional contributions to the field of cancer research.

Join the 2nd Swiss Translational Medicine Conference, dedicated to translational medicine and entrepreneurship. Participants will gain insights into cutting-edge examples of how basic research, once completed, evolves into practical applications. This conference will highlight the various steps required along the translational journey, culminating in products or services that benefit society.